Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Nutr ; 144(2): 185-92, 2014 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-24306215

RESUMEN

Nutritional research has shifted recently from alleviating nutrient deficiencies to chronic disease prevention. We investigated the activity of indicaxanthin, a bioavailable phytochemical of the betalain class from the edible fruit of Opuntia ficus-indica (L. Miller) in a rat model of acute inflammation. Rat pleurisy was achieved by injection of 0.2 mL of λ-carrageenin in the pleural cavity, and rats were killed 4, 24, and 48 h later; exudates were collected to analyze inflammatory parameters, such as nitric oxide (NO), prostaglandin E(2) (PGE(2)), interleukin-1ß (IL-1ß), and tumor necrosis factor-α (TNF-α); cells recruited in pleura were analyzed for cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS) expression, and nuclear factor κ-light-chain-enhancer of activated B cells (NF-κB) activation. Indicaxanthin (0.5, 1, or 2 µmol/kg), given orally before carrageenin, time- and dose-dependently, reduced the exudate volume (up to 70%) and the number of leukocytes recruited in the pleural cavity (up to 95%) at 24 h. Pretreatment with indicaxanthin at 2 µmol/kg inhibited the carrageenin-induced release of PGE(2) (91.4%), NO (67.7%), IL-1ß (53.6%), and TNF-α (71.1%), and caused a decrease of IL-1ß (34.5%), TNF-α (81.6%), iNOS (75.2%), and COX2 (87.7%) mRNA, as well as iNOS (71.9%) and COX-2 (65.9%) protein expression, in the recruited leukocytes. Indicaxanthin inhibited time- and dose- dependently the activation of NF-κB, a key transcription factor in the whole inflammatory cascade. A pharmacokinetic study with a single 2 µmol/kg oral administration showed a maximum 0.22 ± 0.02 µmol/L (n = 15) plasma concentration of indicaxanthin, with a half-life of 1.15 ± 0.11 h. When considering the high bioavailability of indicaxanthin in humans, our findings suggest that this dietary pigment has the potential to improve health and prevent inflammation-based disorders.


Asunto(s)
Antiinflamatorios/uso terapéutico , Betaxantinas/uso terapéutico , Mediadores de Inflamación/metabolismo , Inflamación/dietoterapia , Opuntia/química , Fitoterapia , Pleuresia/dietoterapia , Piridinas/uso terapéutico , Animales , Antiinflamatorios/farmacología , Betaxantinas/farmacología , Carragenina , Modelos Animales de Enfermedad , Frutas/química , Inflamación/inducido químicamente , Inflamación/tratamiento farmacológico , Inflamación/metabolismo , Leucocitos/metabolismo , Masculino , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico , Cavidad Pleural/efectos de los fármacos , Cavidad Pleural/metabolismo , Pleuresia/inducido químicamente , Pleuresia/tratamiento farmacológico , Pleuresia/metabolismo , Piridinas/farmacología , ARN Mensajero/metabolismo , Ratas , Ratas Wistar
2.
Br J Nutr ; 111(3): 415-23, 2014 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-23931157

RESUMEN

Dietary redox-active/antioxidant phytochemicals may help control or mitigate the inflammatory response in chronic inflammatory bowel disease (IBD). In the present study, the anti-inflammatory activity of indicaxanthin (Ind), a pigment from the edible fruit of cactus pear (Opuntia ficus-indica, L.), was shown in an IBD model consisting of a human intestinal epithelial cell line (Caco-2 cells) stimulated by IL-1ß, a cytokine known to play a major role in the initiation and amplification of inflammatory activity in IBD. The exposure of Caco-2 cells to IL-1ß brought about the activation of NADPH oxidase (NOX-1) and the generation of reactive oxygen species (ROS) to activate intracellular signalling leading to the activation of NF-κB, with the over-expression of inflammatory enzymes and release of pro-inflammatory mediators. The co-incubation of the cells with Ind, at a nutritionally relevant concentration (5-25 µM), and IL-1ß prevented the release of the pro-inflammatory cytokines IL-6 and IL-8, PGE2 and NO, the formation of ROS and the loss of thiols in a dose-dependent manner. The co-incubation of the cells with Ind and IL-1ß also prevented the IL-1ß-induced increase of epithelial permeability. It was also shown that the activation of NOX-1 and NF-κB was prevented by Ind and the expression of COX-2 and inducible NO synthase was reduced. The uptake of Ind in Caco-2 cell monolayers appeared to be unaffected by the inflamed state of the cells. In conclusion, our findings suggest that the dietary pigment Ind may have the potential to modulate inflammatory processes at the intestinal level.


Asunto(s)
Antioxidantes/metabolismo , Betaxantinas/metabolismo , Enterocitos/metabolismo , Mediadores de Inflamación/antagonistas & inhibidores , Interleucina-1beta/antagonistas & inhibidores , NADPH Oxidasas/antagonistas & inhibidores , FN-kappa B/antagonistas & inhibidores , Piridinas/metabolismo , Antioxidantes/aislamiento & purificación , Antioxidantes/uso terapéutico , Betaxantinas/aislamiento & purificación , Betaxantinas/uso terapéutico , Células CACO-2 , Permeabilidad de la Membrana Celular , Ciclooxigenasa 2/química , Ciclooxigenasa 2/metabolismo , Enterocitos/inmunología , Activación Enzimática , Frutas/química , Humanos , Mediadores de Inflamación/metabolismo , Enfermedades Inflamatorias del Intestino/dietoterapia , Enfermedades Inflamatorias del Intestino/inmunología , Enfermedades Inflamatorias del Intestino/metabolismo , Interleucina-1beta/metabolismo , Interleucina-6/antagonistas & inhibidores , Interleucina-6/metabolismo , Interleucina-8/antagonistas & inhibidores , Interleucina-8/metabolismo , Absorción Intestinal , NADPH Oxidasa 1 , NADPH Oxidasas/química , NADPH Oxidasas/metabolismo , FN-kappa B/agonistas , FN-kappa B/metabolismo , Óxido Nítrico Sintasa de Tipo II/antagonistas & inhibidores , Óxido Nítrico Sintasa de Tipo II/metabolismo , Opuntia/química , Piridinas/aislamiento & purificación , Piridinas/uso terapéutico , Especies Reactivas de Oxígeno/antagonistas & inhibidores , Especies Reactivas de Oxígeno/metabolismo
3.
Br J Nutr ; 110(2): 230-40, 2013 Jul 28.
Artículo en Inglés | MEDLINE | ID: mdl-23228674

RESUMEN

7-Ketocholesterol (7-KC)-induced apoptosis of macrophages is considered a key event in the development of human atheromas. In the present study, the effect of indicaxanthin (Ind), a bioactive pigment from cactus pear fruit, on 7-KC-induced apoptosis of human monocyte/macrophage THP-1 cells was investigated. A pathophysiological condition was simulated by using amounts of 7-KC that can be reached in human atheromatous plaque. Ind was assayed within a micromolar concentration range, consistent with its plasma level after dietary supplementation with cactus pear fruit. Pro-apoptotic effects of 7-KC were assessed by cell cycle arrest, exposure of phosphatidylserine at the plasma membrane, variation of nuclear morphology, decrease of mitochondrial trans-membrane potential, activation of Bcl-2 antagonist of cell death and poly(ADP-ribose) polymerase-1 cleavage. Kinetic measurements within 24 h showed early formation of intracellular reactive oxygen species over basal levels, preceding NADPH oxidase-4 (NOX-4) over-expression and elevation of cytosolic Ca²âº, with progressive depletion of total thiols. 7-KC-dependent activation of the redox-sensitive NF-κB was observed. Co-incubation of 2·5 µm of Ind completely prevented 7-KC-induced pro-apoptotic events. The effects of Ind may be ascribed to inhibition of NOX-4 basal activity and over-expression, inhibition of NF-κB activation, maintaining cell redox balance and Ca homeostasis, with prevention of mitochondrial damage and consequently apoptosis. The findings suggest that Ind, a highly bioavailable dietary phytochemical, may exert protective effects against atherogenetic toxicity of 7-KC at a concentration of nutritional interest.


Asunto(s)
Apoptosis/efectos de los fármacos , Betaxantinas/farmacología , Calcio/metabolismo , Cetocolesteroles/efectos adversos , Opuntia/química , Estrés Oxidativo/efectos de los fármacos , Extractos Vegetales/farmacología , Piridinas/farmacología , Aterosclerosis/prevención & control , Betaxantinas/sangre , Betaxantinas/uso terapéutico , Línea Celular , Citosol/metabolismo , Suplementos Dietéticos , Frutas , Humanos , Cetocolesteroles/metabolismo , Macrófagos/efectos de los fármacos , Macrófagos/metabolismo , Mitocondrias/efectos de los fármacos , Monocitos/efectos de los fármacos , Monocitos/metabolismo , NADPH Oxidasa 4 , NADPH Oxidasas/metabolismo , FN-kappa B/metabolismo , Fitoterapia , Placa Aterosclerótica/prevención & control , Piridinas/sangre , Piridinas/uso terapéutico , Especies Reactivas de Oxígeno/metabolismo , Compuestos de Sulfhidrilo/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...